Session will be WebcastNEW YORK, June 5, 2026 /PRNewswire/ -- Mark Grant, Senior Vice President of Investor Relations and Treasurer of S&P Global (NYSE: SPGI),...
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on June 1, 2026 (the “Grant Date”), ORIC granted a total of 34,800 non-qualified stock options and 5,900 restricted stock units to two new non-executive employees who began their employment with ORIC in May 2026.
Innovative programs, partnerships and hands-on experiences position Auburn as a leader in advancing reading successAUBURN, Ala., June 5, 2026 /PRNewswire/ -- Auburn University's College of...
Recipients include three nonprofit organizations CHATTANOOGA, Tenn., June 5, 2026 /PRNewswire/ -- The American Water Charitable Foundation, a philanthropic non-profit organization established by American Water (NYSE:...
From Extreme Weather Science and Cybersecurity to Indigenous Cultural Preservation — New Releases Spotlight the Systems Shaping Humanity's FutureNEW YORK, June 5, 2026 /PRNewswire/...
GEORGE TOWN, Cayman Islands, June 05, 2026 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water treatment plants, today announced that its board of directors has approved a quarterly cash dividend of $0.14 per share for the third quarter of 2026.
DALLAS, June 05, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 1, 2026, the Compensation Committee of Taysha's Board of Directors granted four new employees, in the aggregate, restricted stock units (RSUs) representing 714,700 shares of the Company’s common stock and an option to purchase 468,600 shares of the Company's common stock in connection with their employment. The RSUs and stock option were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
Faith in Music Foundation Grant Helps Independent Artist Counter Culture of Nihilism Through Electronic Dance MusicORLANDO, Fla., June 4, 2026 /PRNewswire/ -- Grammy-winning artist Kaya...
The fast-casual favorite known for its flame-frilled chicken marks the summer's biggest tournament with first Free Chicken and Chips Day on June 12th, watch...